Effect of high-dose fentanyl anaesthesia on the metabolic and endocrine response to cardiac surgery.
The effect of high-dose fentanyl anaesthesia (75 micrograms kg-1) on the metabolic and endocrine responses to cardiac surgery was compared with results obtained in similar patients who had received incremental doses of papaveretum. High-dose fentanyl anaesthesia prevented the increases in blood glucose, plasma cortisol and plasma growth hormone concentrations found before cardiopulmonary bypass, but during cardiopulmonary bypass was only effective in decreasing the hyperglycaemia. The continued administration of fentanyl following operation failed to suppress the hormonal and metabolic changes so that the total urinary excretion during the first 5 days after surgery was similar in both groups of patients. High-dose fentanyl anaesthesia was associated with only transient metabolic benefits confined to the period during operation.
D000771:Anesthesia, Intravenous; D001021:Aortic Valve / Q000601:surgery*; D001786:Blood Glucose / Q000378:metabolism; D002315:Cardiopulmonary Bypass; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage*; D013006:Growth Hormone / Q000097:blood; D006349:Heart Valve Diseases / Q000601:surgery; D006728:Hormones / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008660:Metabolism / Q000187:drug effects*; D008875:Middle Aged; D009584:Nitrogen / Q000652:urine; D010208:Papaverine / Q000494:pharmacology
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D006728:Hormones; D013006:Growth Hormone; D010208:Papaverine; D009584:Nitrogen; D005283:Fentanyl; D006854:Hydrocortisone